Insights On Outsourced Drug Development

31. Neuroinflammation In Alzheimer's Disease Pathway 3/24/2025

    Recent research highlights neuroinflammation's role in AD progression, which suggests immune modulation as a potential therapeutic strategy. Learn more about neuroinflammatory processes in AD pathology.

32. The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly 3/3/2025

    In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.

33. The Flux Performance Of Nanoformed And Untreated PRX Solid Suspensions 7/26/2023

    Explore the application of in vitro flux assays to nanoparticles, with data on how the in vitro permeability apparatus can characterize the membrane flux performance of an API formulated as a nanosuspension.

34. MAPK Signaling Pathway 4/7/2025

    Mitogen-activated protein kinase cascades regulate key cellular processes like proliferation, differentiation, and apoptosis. Explore how these pathways maintain cellular homeostasis and contribute to disease development.

35. Ophthalmic Drug Delivery 4/11/2024

    Explore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems.

36. Automation To Miniaturize In Vitro Assays To Achieve Superior And Cost-Efficient Results 5/13/2025

    Here, we present a study showcasing the successful application of miniaturized biochemical assays to screen a diverse range of drug candidates against multiple target molecules.

37. What Is The FusionOptics Technology? 1/8/2024

    Learn about stereo microscopes that combine high resolution and depth of field to provide a superior 3D perception of samples.

38. Formulating Better ASDs And mAbs: Advances In Applied Nanotechnology 5/1/2024

    Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.

39. Peptones And Vaccines: A Synergistic Approach To Enhanced Production And Efficiency 6/2/2025

    Enhance your vaccine manufacturing with peptones. Explore their benefits, analyze data-driven productivity gains, and learn integration strategies in this informative, on-demand session.

40. Nitrosamine Impurities Deadline: Are Your Products Compliant? 11/6/2023

    The FDA nitrosamine contamination guidance set a deadline of August 1, 2025, for all drug manufacturers and market authorization holders to comply fully with the NDSRI limits set.